Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice.
about
Structural characteristics of peptidoglycan fragments required to prime mice for induction of anaphylactoid reactions by lipopolysaccharides.Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components.Structural requirements of muramylpeptides for induction of necrosis at sites primed with Mycobacterium tuberculosis in guinea pigsPeptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling.Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides.Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock.Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.Organ injury and cytokine release caused by peptidoglycan are dependent on the structural integrity of the glycan chain.Synergism between muramyl dipeptide and lipopolysaccharide in the inhibition of glycosaminoglycan synthesis in cultured rat costal chondrocytes.Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.
P2860
Q35470267-DA5E0A11-78D8-482E-B5E3-DFE750EF5D06Q36407841-FF02063F-B0B9-49DD-B465-19780AEF20AAQ37019065-40F10DAD-8412-4938-8567-FE4044835BF1Q39391717-C9235455-9A9E-44FB-87C6-B7A7709A8562Q39512262-D600E200-175A-4685-A15C-F68BADF1DC3FQ39519164-D332E13B-9572-4C51-B6AF-A20DCB1C94FBQ39826933-75F2315C-CAEA-4767-B679-A1188F28ADCAQ40527572-5A4BD376-39E8-4999-B51D-9A036D46CF33Q40634630-81051508-84DA-470A-838D-D0CA62604BFCQ41258226-CB35E3C3-BAA2-4732-9680-8C08F5C113B0Q41988798-72AF034A-9FBF-4CB8-B556-BD41F48ED608Q52718664-929A7A56-760B-4516-B487-2AAC56B0B038
P2860
Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1987
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancement of endotoxin letha ...... uramyl-dipeptide-treated mice.
@en
Enhancement of endotoxin letha ...... uramyl-dipeptide-treated mice.
@nl
type
label
Enhancement of endotoxin letha ...... uramyl-dipeptide-treated mice.
@en
Enhancement of endotoxin letha ...... uramyl-dipeptide-treated mice.
@nl
prefLabel
Enhancement of endotoxin letha ...... uramyl-dipeptide-treated mice.
@en
Enhancement of endotoxin letha ...... uramyl-dipeptide-treated mice.
@nl
P2860
P1476
Enhancement of endotoxin letha ...... uramyl-dipeptide-treated mice.
@en
P2093
P2860
P304
P407
P577
1987-02-01T00:00:00Z